Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20930482 | 0.83 | HCAR2 (0.44) | HCAR2KEAP1NFE2L2ALDH1A1KDM4E | |
| SCHEMBL286132 | 0.76 | HCAR2 (0.40) | HCAR2KEAP1NFE2L2ALDH1A1 | |
| SCHEMBL286129 | 0.76 | HCAR2 (0.40) | HCAR2KEAP1NFE2L2ALDH1A1 | |
| SCHEMBL286130 | 0.76 | HCAR2 (0.40) | HCAR2KEAP1NFE2L2ALDH1A1 | |
| SCHEMBL8996514 | 0.72 | HCAR2 (0.37) | HCAR2KEAP1NFE2L2ALDH1A1KDM4E | |
| SCHEMBL14012897 | 0.72 | HCAR2 (0.46) | HCAR2KEAP1NFE2L2ALDH1A1KDM4E | |
| SCHEMBL14767817 | 0.72 | HCAR2 (0.46) | HCAR2KEAP1NFE2L2ALDH1A1KDM4E | |
| SCHEMBL6252114 | 0.70 | NAPRT (0.46) | ALDH1A1MAPTLMNASMN1; SMN2TSHR | |
| SCHEMBL3120714 | 0.70 | NAPRT (0.46) | ALDH1A1MAPTLMNASMN1; SMN2TSHR | |
| SCHEMBL3120709 | 0.70 | NAPRT (0.46) | ALDH1A1MAPTLMNASMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118355117-A | Oligonucleotide compositions and methods thereof | 波涛生命科学有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118139977-A | Double-stranded oligonucleotide compositions and methods relating thereto | 波涛生命科学有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118139629-A | Compositions and methods for editing MECP2 transcripts | 波涛生命科学有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-112300172-B | Bruton tyrosine kinase inhibitors | 比奥根MA公司 | 2024-01-16 | — | — | CN | disclosed |
| CN-111263768-B | anticancer peptides | IDP研发制药有限公司 | 2023-10-13 | — | — | CN | disclosed |
| CN-116546989-A | N-acetylgalactosamine (GalNAc) derived compounds and oligonucleotides | 阿达尔克斯制药有限公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-116507724-A | Oligonucleotide compositions and methods thereof | 波涛生命科学有限公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-116323638-A | Stapled peptides and methods thereof | 弗格制药有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116113621-A | Amino acids | 弗格制药有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-109071622-B | Peptides with anticancer activity | IDP研发制药有限公司（ES） | 2023-01-13 | — | — | CN | disclosed |
| CN-111511761-A | Anticancer peptides | IDP研发制药有限公司 | 2020-08-07 | — | — | CN | disclosed |
| CN-111436200-A | Anticancer peptides | IDP研发制药有限公司 | 2020-07-21 | — | — | CN | disclosed |
| CN-111201024-A | Chemically modified oligonucleotides | 菲奥医药公司 | 2020-05-26 | — | — | CN | disclosed |
| CN-111032628-A | Process for preparing tert-butyl (S) -4, 5-diamino-5-oxovalerate | 细胞基因公司 | 2020-04-17 | — | — | CN | disclosed |
| CN-110730666-A | Triterpene saponin analogues | 佐剂技术公司 | 2020-01-24 | — | — | CN | disclosed |
| CN-106074591-B | RNA interference in ocular symptoms | 菲奥医药公司 | 2020-01-14 | — | — | CN | disclosed |
| CN-110621678-A | Antitumor compounds | 法马马有限公司 | 2019-12-27 | — | — | CN | disclosed |
| CN-106963514-B | Urinary device | 科洛普拉斯特公司 | 2019-12-17 | — | — | CN | disclosed |
| CN-110582282-A | Triterpene saponin analogues | 佐剂技术公司 | 2019-12-17 | — | — | CN | disclosed |
| CN-105792852-B | Glucose-responsive insulin conjugates | 默沙东公司 | 2019-12-10 | — | — | CN | disclosed |